Following the FDA’s recent announcement postponing meetings in response to COVID-19, the ISPOR-FDA Summit is postponed to a later date that will be announced once available. Learn More

The ISPOR-FDA Summit 2020 is POSTPONED. This Summit will no longer take place on the original scheduled date of March 31, 2020. Please check back for a new scheduled date and location!

Patient-preference information (PPI) is increasingly being used in regulatory decision making for medical devices. This Summit will provide a forum to engage all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem.

Jointly sponsored by ISPOR—the professional society for health economics and outcomes research—and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), this Summit offers several avenues for engagement and learning…

View an ISPOR Educational Webinar on this topic: Patient-Preference Information – What It Is and What It Is Not

ISPOR-logo

 

U.S. Food and Drug Administration (FDA)

Costs for this event were partially covered through unrestricted grants from the following organizations:
CVRx Inc., Edwards Lifesciences, and Evidation Health